DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 52-Week Low – Should You Sell?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY)’s stock price reached a new 52-week low during trading on Wednesday. The stock traded as low as $8.38 and last traded at $8.4420, with a volume of 186155 shares. The stock had previously closed at $8.52.

Wall Street Analyst Weigh In

XRAY has been the topic of several research reports. BMO Capital Markets cut their price target on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating on the stock in a report on Thursday, September 17th. Barclays upped their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the company an “underweight” rating in a report on Monday, August 24th. Piper Sandler raised their target price on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. Barrington Research set a $15.00 price target on shares of DENTSPLY SIRONA in a report on Monday, August 10th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DENTSPLY SIRONA in a report on Monday, August 3rd. Three equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $13.31.

DENTSPLY SIRONA Stock Down 0.6%

The stock has a market capitalization of $1.69 billion, a price-to-earnings ratio of -3.08, a price-to-earnings-growth ratio of 1.09 and a beta of 0.87. The business’s 50-day moving average is $10.91 and its two-hundred day moving average is $11.19. The company has a quick ratio of 1.07, a current ratio of 1.63 and a debt-to-equity ratio of 1.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The company had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. During the same quarter in the prior year, the firm earned $0.52 EPS. DENTSPLY SIRONA’s quarterly revenue was down 4.1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.4 EPS for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Envestnet Portfolio Solutions Inc. grew its holdings in DENTSPLY SIRONA by 42.6% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 60,828 shares of the medical instruments supplier’s stock valued at $645,000 after buying an additional 18,181 shares in the last quarter. Tidal Investments LLC increased its position in DENTSPLY SIRONA by 13.1% during the second quarter. Tidal Investments LLC now owns 371,967 shares of the medical instruments supplier’s stock worth $3,947,000 after purchasing an additional 43,025 shares during the last quarter. Engineers Gate Manager LP raised its stake in DENTSPLY SIRONA by 451.5% during the second quarter. Engineers Gate Manager LP now owns 124,810 shares of the medical instruments supplier’s stock worth $1,324,000 after purchasing an additional 102,179 shares during the period. Integrated Wealth Concepts LLC acquired a new position in DENTSPLY SIRONA in the 2nd quarter valued at about $791,000. Finally, Allworth Financial LP grew its stake in shares of DENTSPLY SIRONA by 163.8% in the 2nd quarter. Allworth Financial LP now owns 4,815 shares of the medical instruments supplier’s stock valued at $51,000 after buying an additional 2,990 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

Dentsply Sirona is a global dental products and technologies company that develops, manufactures and markets solutions for dental professionals, laboratories and patients. Its portfolio includes consumable products, dental equipment and digital technologies used in preventive, restorative, endodontic, orthodontic, implant and prosthetic dentistry.

The company offers dental treatment centers, imaging systems, CAD/CAM systems, intraoral scanners, milling and 3D-printing solutions, instruments, endodontic files and equipment, restorative materials, dental implants, prosthetic components and orthodontic products.